# David Steinberg

> David Steinberg is Chief Business Officer at Formation Bio, an AI-native pharmaceutical company in New York, where he runs in- and out-licensing and pipeline strategy. A serial biotech company builder, he co-founded PureTech Health and served as its Chief Innovation Officer, was a General Partner at Longwood Fund, and founded or led a string of NASDAQ-listed and venture-backed companies including Pyxis Oncology, Vor Biopharma, Vedanta Biosciences and Be Biopharma. He pairs a Cornell biology degree with a University of Chicago Booth MBA and a career that began in R&D and strategy consulting.

- **Role:** Chief Business Officer at Formation Bio
- **Organizations:** Formation Bio, Longwood Fund, PureTech Health, Pyxis Oncology, Vor Biopharma, Vedanta Biosciences, Be Biopharma, Photys Therapeutics, Carbon Biosciences, resTORbio
- **Nationality:** American
- **Education:** BA in Biology, Cornell University, MBA, Strategy and Finance, University of Chicago Booth School of Business
- **Known for:** Co-founded PureTech Health, a pioneering hub-and-spoke biotech company-creation firm, Founded or led multiple NASDAQ-listed companies including Pyxis Oncology (PYXS), Vor Biopharma (VOR) and resTORbio (TORC), Founded or co-founded private venture-backed biotechs including Vedanta Biosciences, Be Biopharma, Photys Therapeutics and Carbon Biosciences

## Career timeline

- **Early career** — R&D at P&G Pharmaceuticals
- **Early career** — Biopharma strategy consulting at Boston Consulting Group and Vertex Partners
- **2002-2018** — Co-founder and Chief Innovation Officer at PureTech Health (NASDAQ/LSE: PRTC)
- **2018** — Joined Longwood Fund as General Partner
- **2018-2024** — Founded and led multiple Longwood companies: Pyxis Oncology, Photys Therapeutics, Be Biopharma, Carbon Biosciences
- **2024** — Appointed Chief Business Officer at Formation Bio

## Achievements

- Co-founded PureTech Health, a pioneering hub-and-spoke biotech company-creation firm
- Founded or led multiple NASDAQ-listed companies including Pyxis Oncology (PYXS), Vor Biopharma (VOR) and resTORbio (TORC)
- Founded or co-founded private venture-backed biotechs including Vedanta Biosciences, Be Biopharma, Photys Therapeutics and Carbon Biosciences
- Founding CEO of Be Biopharma
- Served as Chairman of the Board for Photys Therapeutics and Be Biopharma
- Built and launched Formation Bio's Entrepreneurs in Residence program in 2025

## Latest updates

- **2024** — Appointed Chief Business Officer at Formation Bio, leading in- and out-licensing strategy.
- **2025-06** — Launched Formation Bio's first class of Entrepreneurs in Residence to expand the company's pipeline and partnerships.

## Links

- Website: https://formation.bio
- LinkedIn: http://www.linkedin.com/in/david-steinberg-b492632

---

Profile page: https://yespress.io/david-steinberg
Published by YesPress — https://yespress.io
Last updated: 2026-06-13